Literature DB >> 32225138

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products.

Renata Sigrist1, Bruno S Paulo1, Célio F F Angolini2, Luciana G De Oliveira3.   

Abstract

The chemical space covered by natural products is immense and widely unrecognized. Therefore, convenient methodologies to perform wide-ranging evaluation of their functions in nature and potential human benefits (e.g., for drug discovery applications) are desired. This protocol describes the combination of genome mining (GM) and molecular networking (MN), two contemporary approaches that match gene cluster-encoded annotations in whole genome sequencing with chemical structure signatures from crude metabolic extracts. This is the first step towards the discovery of new natural entities. These concepts, when applied together, are defined here as MS-guided genome mining. In this method, the main components are previously designated (using MN), and structurally related new candidates are associated with genome sequence annotations (using GM). Combining GM and MN is a profitable strategy to target new molecule backbones or harvest metabolic profiles in order to identify analogues from already known compounds.

Entities:  

Year:  2020        PMID: 32225138     DOI: 10.3791/60825

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Nonlinear Biosynthetic Assembly of Alpiniamide by a Hybrid cis/trans-AT PKS-NRPS.

Authors:  Renata Sigrist; Hanna Luhavaya; Shaun M K McKinnie; Amanda Ferreira da Silva; Igor D Jurberg; Bradley S Moore; Luciana Gonzaga de Oliveira
Journal:  ACS Chem Biol       Date:  2020-04-06       Impact factor: 5.100

Review 2.  In vivo and in silico screening for antimicrobial compounds from cyanobacteria.

Authors:  Dorina Strieth; Selina Lenz; Roland Ulber
Journal:  Microbiologyopen       Date:  2022-04       Impact factor: 3.904

3.  Combined mass spectrometry-guided genome mining and virtual screening for acaricidal activity in secondary metabolites of Bacillus velezensis W1.

Authors:  Xingyu Li; Shahzad Munir; Yan Xu; Yuehu Wang; Yueqiu He
Journal:  RSC Adv       Date:  2021-07-21       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.